• Return to Headlines

Shares of Diplomat Pharmac Fall to a New 52-Week Low

By David Diaz

Diplomat Pharmac (NYSE:DPLO) traded at a new 52-week low today of $5.30. This new low was reached on below average trading volume as 670,000 shares traded hands, while the average 30-day volume is approximately 1.8 million shares.

In the past 52 weeks, Diplomat Pharmac share prices have been bracketed by a current low of $5.30 and a high of $28.74 and are now at $5.30. Over the past week, the 200-day moving average (MA) has gone down 2% while the 50-day MA has declined 5%.

Diplomat Pharmac has overhead space with shares priced $5.30, or 78.8% below the average consensus analyst price target of $25.00. The stock should run into initial resistance at its 50-day moving average (MA) of $11.32 and subsequent resistance at its 200-day MA of $17.96.

Diplomat Pharmacy, Inc. is a specialty pharmacy that services patients with complex chronic diseases. The Company aids in the dispensing, delivery, dosing and reimbursement of clinically intensive, high-cost specialty drugs.

SmarTrend recommended that its subscribers protect gains by selling shares of Diplomat Pharmac on November 7th, 2018 by issuing a Downtrend alert when the shares were trading at $14.37. Since that call, shares of Diplomat Pharmac have fallen 55.3%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows diplomat pharmac

Ticker(s): DPLO